Clovis Oncology (CLVS) Defended at SunTrust
Tweet
Share
E-mail
Get Alerts CLVS Hot Sheet
Price: $0.08 --0%
Rating Summary:
7 Buy, 7 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 36
Rating Summary:
7 Buy, 7 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 36
Join SI Premium – FREE
In addition to Piper (noted earlier), SunTrust is out defending Clovis Oncology (NASDAQ: CLVS) saying there nothing significantly new in the data. Shares of CLVS are down 13.7% after trading down nearly 30% earlier.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ionis Pharmaceuticals (IONS) PT Lowered to $70 at JPMorgan Amid Negative Sentiment
- Cantor Fitzgerald Upgrades Omeros Corp. (OMER) to Overweight, 'We May Have Underestimated Yartemlea'
- Melius Starts Williams Companies (WMB) at Buy
Create E-mail Alert Related Categories
Analyst Comments, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
